Acinetobacter nosocomialis: Defining the Role of Efflux Pumps in Resistance to Antimicrobial Therapy, Surface Motility, and Biofilm Formation
- PMID: 30186249
- PMCID: PMC6111201
- DOI: 10.3389/fmicb.2018.01902
Acinetobacter nosocomialis: Defining the Role of Efflux Pumps in Resistance to Antimicrobial Therapy, Surface Motility, and Biofilm Formation
Abstract
Acinetobacter nosocomialis is a member of the Acinetobacter calcoaceticus-Acinetobacter baumannii (ACB) complex. Increasingly, reports are emerging of the pathogenic profile and multidrug resistance (MDR) phenotype of this species. To define novel therapies to overcome resistance, we queried the role of the major efflux pumps in A. nosocomialis strain M2 on antimicrobial susceptibility profiles. A. nosocomialis strains with the following mutations were engineered by allelic replacement; ΔadeB, ΔadeJ, and ΔadeB/adeJ. In these isogenic strains, we show that the ΔadeJ mutation increased susceptibility to beta-lactams, beta-lactam/beta-lactamase inhibitors, chloramphenicol, monobactam, tigecycline, and trimethoprim. The ΔadeB mutation had a minor effect on resistance to certain beta-lactams, rifampicin and tigecycline. In addition, the ΔadeJ mutation resulted in a significant decrease in surface motility and a minor decrease in biofilm formation. Our results indicate that the efflux pump, AdeIJK, has additional roles outside of antibiotic resistance in A. nosocomialis.
Keywords: Acinetobacter; RND-efflux; antimicrobial resistance; biofilm; motility.
Figures


Similar articles
-
Contribution of resistance-nodulation-cell division efflux systems to antibiotic resistance and biofilm formation in Acinetobacter baumannii.mBio. 2015 Mar 24;6(2):e00309-15. doi: 10.1128/mBio.00309-15. mBio. 2015. PMID: 25805730 Free PMC article.
-
Overexpression of AdeABC efflux pump associated with tigecycline resistance in clinical Acinetobacter nosocomialis isolates.Clin Microbiol Infect. 2019 Apr;25(4):512.e1-512.e6. doi: 10.1016/j.cmi.2018.06.012. Epub 2018 Jun 12. Clin Microbiol Infect. 2019. PMID: 29906589
-
Inhibition of AdeB, AceI, and AmvA Efflux Pumps Restores Chlorhexidine and Benzalkonium Susceptibility in Acinetobacter baumannii ATCC 19606.Front Microbiol. 2022 Feb 7;12:790263. doi: 10.3389/fmicb.2021.790263. eCollection 2021. Front Microbiol. 2022. PMID: 35197939 Free PMC article.
-
Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.Folia Histochem Cytobiol. 2008;46(3):257-67. doi: 10.2478/v10042-008-0056-x. Folia Histochem Cytobiol. 2008. PMID: 19056528 Review.
-
Regulation of the AcrAB efflux system by the quorum-sensing regulator AnoR in Acinetobacter nosocomialis.J Microbiol. 2020 Jun;58(6):507-518. doi: 10.1007/s12275-020-0185-2. Epub 2020 May 27. J Microbiol. 2020. PMID: 32462488 Review.
Cited by
-
Roles of Efflux Pumps from Different Superfamilies in the Surface-Associated Motility and Virulence of Acinetobacter baumannii ATCC 17978.Antimicrob Agents Chemother. 2019 Feb 26;63(3):e02190-18. doi: 10.1128/AAC.02190-18. Print 2019 Mar. Antimicrob Agents Chemother. 2019. PMID: 30642939 Free PMC article.
-
Metagenomics-based tracing of genetically modified microorganism contaminations in commercial fermentation products.Food Chem (Oxf). 2024 Dec 24;10:100236. doi: 10.1016/j.fochms.2024.100236. eCollection 2025 Jun. Food Chem (Oxf). 2024. PMID: 39834589 Free PMC article.
-
Impact of an Intervention to Control Imipenem-Resistant Acinetobacter baumannii and Its Resistance Mechanisms: An 8-Year Survey.Front Microbiol. 2021 Feb 16;11:610109. doi: 10.3389/fmicb.2020.610109. eCollection 2020. Front Microbiol. 2021. PMID: 33664711 Free PMC article.
-
Microbiological quality analysis of inoculants based on Bradyrhizobium spp. and Azospirillum brasilense produced "on farm" reveals high contamination with non-target microorganisms.Braz J Microbiol. 2022 Mar;53(1):267-280. doi: 10.1007/s42770-021-00649-2. Epub 2022 Jan 1. Braz J Microbiol. 2022. PMID: 34984661 Free PMC article.
-
Identification of Novel Acinetobacter baumannii Host Fatty Acid Stress Adaptation Strategies.mBio. 2019 Feb 5;10(1):e02056-18. doi: 10.1128/mBio.02056-18. mBio. 2019. PMID: 30723122 Free PMC article.
References
-
- Chusri S., Chongsuvivatwong V., Rivera J. I., Silpapojakul K., Singkhamanan K., McNeil E., et al. . (2014). Clinical outcomes of hospital-acquired infection with Acinetobacter nosocomialis and Acinetobacter pittii. Antimicrob. Agents Chemother. 58, 4172–4179. 10.1128/AAC.02992-14 - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources